Pharmaceutical companies formed cluster

Pharmaceutical companies Roche, Merck Serono and Abbott announced to join forces in the development of the Biotechnology Cluster Rhine-Neckar (BioRN) towards a leading position in the field of medical biotechnology in Europe.

According to Chief Executive Officer of the Roche Diagnostics Division, the success of the BioRN cluster, which brings together some 100 partners in business and research, rests partly on the excellent pioneering research being done here in the Rhine-Neckar region.

Roche and Merck Serono, together with major research institutions and small biotechnology companies in the Rhine-Neckar metropolitan region, already participate in the BioRN cluster activities with projects for the development of novel drugs and diagnostics, as well as special education programs for talented life scientists, managers and entrepreneurs.

Source: Фармацевтический вестник